Healthicare vs PeptidesRx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Healthicare
Best for buyers who want a transparent, named-clinician + named-pharmacy compounded GLP-1 option in 44 statesStarting at $148/mo
PeptidesRx
Best for patients prioritizing regulatory compliance in the compounded spaceStarting at $169/mo
Side-by-Side Comparison
| Feature | Healthicare | PeptidesRx |
|---|---|---|
| Overall Score | 7.1/10 | ✓7.9/10 |
| Starting Price | ✓$148/mo | $169/mo |
| Editorial Rating | 3.6 ★ /5 | ✓4 ★ /5 |
| Features | ✓7 features | 6 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Healthicare
Pros
- ✓Both compounded and full brand-name GLP-1 menu (Ozempic, Wegovy, Mounjaro, Zepbound) on one platform
- ✓Pharmacy partner is publicly named: F&F Pharmacies Inc. dba Jungle Jim's Pharmacy, 5484 Dixie Highway, Fairfield, OH 45014, (877) 858-3784
- ✓Clinical lead is publicly named: Dr. Jonah Mink, 618.740.4204, Beluga Health
- ✓Compounded semaglutide first dose at $147.90/mo is on the lower end of the segment
Cons
- ✗Not available in 6 states: CA, NV, NJ, NC, TX, MA, MS, NH, WV, DE (verify the explicit list before sending readers)
- ✗Brand-name first-month pricing of $1,199.99–$1,299.99 is at or above retail without insurance — most of the value here is on the compounded tier
- ✗Brand ownership: 'Sunshine Health Studios Inc.' is referenced in the footer — relationship to the healthicare.com domain owner needs independent confirmation
PeptidesRx
Pros
- ✓Compliance-focused positioning vs gray-market vendors
- ✓Board-certified medical director
- ✓Transparent pricing with no surprise fees
- ✓Real prescriptions, not research-chemical channel
Cons
- ✗Smaller scale than Henry Meds or Hims
- ✗Wide peptide menu may distract from GLP-1 focus
Our Verdict
PeptidesRx edges out Healthicare with a higher overall score of 7.9/10 and is particularly strong for patients prioritizing regulatory compliance in the compounded space. Healthicare remains a solid alternative, especially if you're looking for buyers who want a transparent, named-clinician + named-pharmacy compounded GLP-1 option in 44 states.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.